BlossomHill Therapeutics, Inc. (BLSM) vs ProKidney Corp. (PROK)

A side-by-side comparison of BlossomHill Therapeutics, Inc. and ProKidney Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
BlossomHill Therapeutics, Inc. logo
BLSM
BlossomHill Therapeutics, Inc.
$553M
$19.00HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT
ProKidney Corp. logo
PROK
ProKidney Corp.
$536M
$1.60HealthcareDelayed quote: Oct 6, 2026, 12:14 PM EDT

Total return — BLSM vs PROK

growth of $100 · dividends reinvested · last 1y
BLSM +24.6% (+24.6%/yr)PROK -3.7% (-3.7%/yr)BLSM compounded faster over this window
80100120140160Start $100$125$96
BLSM PROK

BLSM vs PROK: by the numbers

  • •BLSM is the larger company ($553M vs $536M market cap).
  • •Both run net losses; BLSM's is the smaller (0.00% vs -10599.76% net margin).

Metrics side by side

Valuation

MetricBLSMPROK
P/S ratioN/A655.65

Profitability

MetricBLSMPROK
Gross margin0.00%100.00%
Operating margin0.00%-18477.83%
Net margin0.00%-10599.76%
ROIC-43.41%-78.31%

Growth (annualized)

MetricBLSMPROK
Total return CAGR (5Y)N/A-30.65%

Go deeper

Full BLSM analysisFull PROK analysisInteractive comparison tool

Dig into the metrics

BlossomHill Therapeutics ROEProKidney ROEBlossomHill Therapeutics operating marginProKidney operating marginBlossomHill Therapeutics revenue growthProKidney revenue growthBlossomHill Therapeutics free cash flowProKidney free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.